Kusumoto H, Hirosawa S, Salier J P, Hagen F S, Kurachi K
Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618.
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7307-11. doi: 10.1073/pnas.85.19.7307.
Complementary DNA clones for human C1s were isolated from cDNA libraries that were prepared with poly(A)+ RNAs of human liver and HepG2 cells. A clone with the largest cDNA insert of 2664 base pairs (bp) was analyzed for its complete nucleotide sequence. It contained 202 bp of a 5' untranslated region, 45 bp of coding for a signal peptide (15 amino acid residues), 2019 bp for complement component C1s zymogen (673 amino acid residues), 378 bp for a 3' untranslated region, a stop codon, and 17 bp of a poly(A) tail. The amino acid sequence of C1s was 40.5% identical to that of C1r, with excellent matches of tentative disulfide bond locations conserving the overall domain structure of C1r. DNA blotting and sequencing analyses of genomic DNA and of an isolated genomic DNA clone clearly showed that the human genes for C1r and C1s are closely located in a "tail-to-tail" arrangement at a distance of about 9.5 kilobases. Furthermore, RNA blot analyses showed that both C1r and C1s genes are primarily expressed in liver, whereas most other tissues expressed both C1r and C1s genes at much lower levels (less than 10% of that in liver). Multiple molecular sizes of specific mRNAs were observed in the RNA blot analyses for both C1r and C1s, indicating that alternative RNA processing(s), likely an alternative polyadenylylation, might take place for both genes.
从用人肝脏和HepG2细胞的聚腺苷酸加尾RNA制备的cDNA文库中分离出了人C1s的互补DNA克隆。对一个具有2664个碱基对(bp)最大cDNA插入片段的克隆进行了完整核苷酸序列分析。它包含202bp的5'非翻译区、编码信号肽(15个氨基酸残基)的45bp、补体成分C1s酶原的2019bp(673个氨基酸残基)、3'非翻译区的378bp、一个终止密码子以及17bp的聚腺苷酸尾。C1s的氨基酸序列与C1r的氨基酸序列有40.5%的同一性,暂定二硫键位置的匹配度很高,保留了C1r的整体结构域结构。对基因组DNA和一个分离的基因组DNA克隆进行的DNA印迹和测序分析清楚地表明,人C1r和C1s基因以“尾对尾”的排列紧密定位,距离约为9.5千碱基。此外,RNA印迹分析表明,C1r和C1s基因主要在肝脏中表达,而大多数其他组织中C1r和C1s基因的表达水平要低得多(低于肝脏中的10%)。在C1r和C1s的RNA印迹分析中观察到了特定mRNA的多种分子大小,这表明这两个基因可能发生了替代RNA加工,可能是替代聚腺苷酸化。